RNU6ATAC39P

Across TCGA pan-cancer cohorts, RNU6ATAC39P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RNU6ATAC39P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU6ATAC39P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6ATAC39P expression acts as an unfavorable survival marker, although some lineages such as MESO and HNSC show a favorable association.

READ, KIRC, and UCS are the cancer types where RNU6ATAC39P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.258	0.824	<.001	66	view →
KIRC	OS	Median	All	0.518	0.709	.001	46	view →
UCS	DFS	Tertile	IV	0.230	0.767	.009	36	view →
LAML	DFS	Tertile	All	0.433	0.684	.005	32	view →
MESO	DFS	Quartile	All	0.595	0.338	.003	30	view →
HNSC	OS	Tertile	II,III,IV	0.458	0.307	.009	28	view →
BLCA	DFS	Median	III,IV	0.623	0.493	.006	23	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
OV	OS	Quartile	III,IV	0.425	0.328	.024	6	view →
ESCA	OS	Tertile	IV	0.743	0.393	.024	6	view →
LGG	OS	Quartile	All	0.814	0.905	.015	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RNU6ATAC39P–READ (OS)

Open the READ breakdown →